Camber Pharma Launches Generic Neurontin®

Piscataway, NJ, November 17, 2021– Camber Pharmaceuticals is pleased to announce that it has added Gabapentin Tablets to their current portfolio, which is the generic version of Neurontin®
Gabapentin Tablets are used together with other medicines to treat partial seizures in adults and children at least 3 years old.
Gabapentin Tablets from Camber are available in 600 and 800 mg strengths in 100 and 500 bottle counts.
To find out more about Gabapentin Tablets please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection